APOB and metabolic syndrome: These results are consistent with findings from Ojanen et al. [20], who identified the Apolipoprotein B/Apolipoprotein A-1 ratio and glycoprotein acetyls as predictors of metabolic syndrome, reinforcing the concept that changes in lipoproteins and fatty acid composition may serve as useful biomarkers for cardiometabolic risk.